Anti-metastasis therapy: BMP4 inhibits epithelial-mesenchymal transiton and ZEB2 expression via up regulation of its target gene, 10/October/2014, 22.36

Anti-metastasis therapy: BMP4 inhibits epithelial-mesenchymal transiton and ZEB2 expression via up regulation of its target gene, 10/October/2014, 22.36

Anti-metastasis therapy: BMP4 inhibits epithelial-mesenchymal transiton and ZEB2 expression via up regulation of its target gene, 10/October/2014, 22.36 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

CitationBoominathan, L., Anti-metastasis therapy: BMP4 inhibits epithelial-mesenchymal transiton and ZEB2 expression via up regulation of its target gene, 10/October/2014, 22.36, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Significance: This study suggests that tumor suppressor BMP4, by increasing the expression of its target gene, it may decrease the expression of EMT protein ZEB2.  Therefore, pharmacological formulations encompassing “BMP4 activators may be used to metastatic cancers.